Korean J Pain.  2019 Jul;32(3):215-222. 10.3344/kjp.2019.32.3.215.

The efficacy of selective nerve root block for the long-term outcome of postherpetic neuralgia

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, Chonbuk National University Medical School, Jeonju, Korea. sjs6803@jbnu.ac.kr
  • 2Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, Korea.
  • 3Department of Preventive Medicine, Chonbuk National University Medical School, Jeonju, Korea.

Abstract

BACKGROUND
Several nerve blocks can reduce the incidence of postherpetic neuralgia (PHN) as well as relieve acute zoster-related pain, but the long-term outcome of PHN has not been clearly determined. This study investigated the efficacy of selective nerve root block (SNRB) for herpes zoster (HZ) on the long-term outcome of PHN.
METHODS
We prospectively conducted an interview of patients who had undergone an SNRB for HZ from January 2006 to December 2016 to evaluate their long-term PHN status. The relationship between the time from HZ onset to the first SNRB and the long-term outcome of PHN was investigated.
RESULTS
The data of 67 patients were collected. The patients were allocated to acute (SNRB ≤ 14 days, n = 16) or subacute (SNRB > 14 days, n = 51) groups. The proportions of cured patients were 62.5% and 25.5% in the acute and subacute groups (P = 0.007), respectively. In logistic regression, an SNRB >14 days was the significant predictor of PHN (adjusted odd ratio, 3.89; 95% confidence interval, 1.02-14.93; P = 0.047). Kaplan-Meier analysis revealed that time from the SNRB to the cure of PHN was significantly shorter in the acute group (2.4 ± 0.7 yr) than in the subacute group (5.0 ± 0.4 yr; P = 0.003).
CONCLUSIONS
An early SNRB during the acute stage of HZ (within 14 days) appears to decrease the incidence and shorten the duration of PHN, with a median of 5.0 years of follow-up.

Keyword

Follow-Up Studies; Ganglia, Spinal; Herpes Zoster; Incidence; Logistic Models; Nerve Block; Neuralgia, Postherpetic; Pain

MeSH Terms

Follow-Up Studies
Ganglia, Spinal
Herpes Zoster
Humans
Incidence
Logistic Models
Nerve Block
Neuralgia, Postherpetic*
Prospective Studies

Figure

  • Fig. 1 Subjects flow diagram. ZRP: zoster-related pain, SNRB: selective nerve root block, HZ: herpes zoster.

  • Fig. 2 Receiver operating characteristic curve. The areas under the curve (AUC) is 0.658 (95% confidence interval, 0.514–0.802; P = 0.035).

  • Fig. 3 Patient-reported long-term severity of postherpetic neuralgia (PHN). Acute group: selective nerve root block (SNRB) ≤ 14 days, subacute group; SNRB >14 days from herpes zoster onset. Details of patients-reported 4-step severity grading of PHN: “relieved”, no pain; “improved”, pain is reduced but remained; “sustained”, painful and no change in pain after treatment; “aggravated”, more painful after treatment. aThe proportions of cured (relieved) patients were 62.5% and 25.5% in acute and subacute groups, respectively, which was significantly different by Mann–Whitney rank-sum test (P = 0.007).

  • Fig. 4 Kaplan–Meier curve. Time from selective nerve root block (SNRB) to complete cure of postherpetic neuralgia (PHN) was significantly shorter in the acute group than in the subacute group (2.4 ± 0.7 years vs. 5.0 ± 0.4 years; P = 0.003 by log-rank test). Acute group: SNRB ≤ 14 days; subacute group: SNRB >14 days from herpes zoster onset.


Reference

1. Forbes HJ, Thomas SL, Smeeth L, Clayton T, Farmer R, Bhaskaran K, et al. A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain. 2016; 157:30–54. DOI: 10.1097/j.pain.0000000000000307. PMID: 26218719. PMCID: PMC4685754.
Article
2. Song H, Lee J, Lee M, Choi WS, Choi JH, Lee MS, et al. Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study. Int J Infect Dis. 2014; 20:23–30. DOI: 10.1016/j.ijid.2013.11.018. PMID: 24412314.
Article
3. Hong MJ, Kim YD, Cheong YK, Park SJ, Choi SW, Hong HJ. Epidemiology of postherpetic neuralgia in Korea: an electronic population health insurance system based study. Medicine (Baltimore). 2016; 95:e3304. DOI: 10.1097/MD.0000000000003304. PMID: 27057902. PMCID: PMC4998818.
4. Kim HJ, Ahn HS, Lee JY, Choi SS, Cheong YS, Kwon K, et al. Effects of applying nerve blocks to prevent postherpetic neuralgia in patients with acute herpes zoster: a systematic review and meta-analysis. Korean J Pain. 2017; 30:3–17. DOI: 10.3344/kjp.2017.30.1.3. PMID: 28119767. PMCID: 5256258.
Article
5. Makharita MY, Amr YM, El-Bayoumy Y. Effect of early stellate ganglion blockade for facial pain from acute herpes zoster and incidence of postherpetic neuralgia. Pain Physician. 2012; 15:467–74. PMID: 23159962.
6. Ji G, Niu J, Shi Y, Hou L, Lu Y, Xiong L. The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Anesth Analg. 2009; 109:1651–5. DOI: 10.1213/ANE.0b013e3181b79075. PMID: 19713253.
Article
7. Eckel TS, Bartynski WS. Epidural steroid injections and selective nerve root blocks. Tech Vasc Interv Radiol. 2009; 12:11–21. DOI: 10.1053/j.tvir.2009.06.004. PMID: 19769903.
Article
8. Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Mansfield K, et al. Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: a cohort study. Neurology. 2016; 87:94–102. DOI: 10.1212/WNL.0000000000002808. PMID: 27287218. PMCID: 4932239.
Article
9. Kumar V, Krone K, Mathieu A. Neuraxial and sympathetic blocks in herpes zoster and postherpetic neuralgia: an appraisal of current evidence. Reg Anesth Pain Med. 2004; 29:454–61. PMID: 15372391.
Article
10. Reichelt M, Zerboni L, Arvin AM. Mechanisms of varicellazoster virus neuropathogenesis in human dorsal root ganglia. J Virol. 2008; 82:3971–83. DOI: 10.1128/JVI.02592-07. PMID: 18256143. PMCID: 2292995.
Article
11. Jeon YH. Herpes zoster and postherpetic neuralgia: practical consideration for prevention and treatment. Korean J Pain. 2015; 28:177–84. DOI: 10.3344/kjp.2015.28.3.177. PMID: 26175877. PMCID: 4500781.
Article
12. Van Zundert J, Hartrick C, Patijn J, Huygen F, Mekhail N, van Kleef M. Evidence-based interventional pain medicine according to clinical diagnoses. Pain Pract. 2011; 11:423–9. DOI: 10.1111/j.1533-2500.2011.00490.x. PMID: 21923721.
Article
13. Kim ED, Bak HH, Jo DH, Park HJ. Clinical efficacy of transforaminal epidural injection for management of zoster-associated pain: a retrospective analysis. Skeletal Radiol. 2018; 47:253–60. DOI: 10.1007/s00256-017-2795-2. PMID: 29051967.
Article
14. Dworkin RH, Gnann JW Jr, Oaklander AL, Raja SN, Schmader KE, Whitley RJ. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain. 2008; 5(1 Suppl):S37–44. DOI: 10.1016/j.jpain.2007.10.008. PMID: 18166464.
Article
15. Kim YJ, Lee CN, Lee MS, Lee JH, Lee JY, Han K, et al. Recurrence rate of herpes zoster and its risk factors: a population-based cohort study. J Korean Med Sci. 2018; 34:e1. DOI: 10.3346/jkms.2019.34.e1. PMID: 30636941. PMCID: PMC6327089.
Article
16. Vassiliev D. Spread of contrast during L4 and L5 nerve root infiltration under fluoroscopic guidance. Pain Physician. 2007; 10:461–6. PMID: 17525780.
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr